Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment

Figure 1 Kaplan-Meier estimates and prognostic factors of overall survival (comparison between each group). Group A, patients without hand-foot skin reaction (HFSR) but with pharmacist intervention; Group B, patients with HFSR and the nonmutual cooperation system; Group C, patients with HFSR and intervention by pharmacists who shared interview information with the oncologist (mutual cooperation system).

Figure 2 Kaplan-Meier estimates and prognostic factors of overall survival (Barcelona Clinic Liver Cancer B vs Barcelona Clinic Liver Cancer C). BCLC: Barcelona Clinic Liver Cancer.

Figure 3 Proportion and prognostic factors of nonadherence. Group A, patients without hand-foot skin reaction (HFSR) but with pharmacist intervention; Group B, patients with HFSR and the nonmutual cooperation system; Group C, patients with HFSR and intervention by pharmacists who shared interview information with the oncologist (mutual cooperation system).